Skip to content

Homoeopathy in diseases of the jaw bone

Individualized homoeopathic medicines in the treatment of temporomandibular joint dysfunction: A double-blind, randomized feasibility trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052919
Enrollment
60
Registered
2023-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M266- Temporomandibular joint disorders

Interventions

Intervention1: Homoeopathic medicines on basis of Individualization: Known pharmacopeial homoeopathic preparations to be used in the study. Dose: In centesimal potencies of 6CH, 30CH, 200CH, 1000CH, 1

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with the complaint of pain at the Temporo Mandibular joint (M26.6) 2. Age: 18 year(s) to 75 year(s) 3. Both sexes 4. Not undertaking regular medicines for any other clinical conditions other than controlled diabetes mellitus, hypertension, hypothyroidism, hypertriglyceridemia and hypercholesteremia 5. Patients suffering from additional acute diseases like acute upper respiratory tract infection, acute gastro-enteritis, acute toothache, and acute sinusitis may be enrolled after a washout period of 1 week following recovery 6. Voluntary written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with self-reported serious co-morbidities like Tuberculosis, Cardiac disorders, HIV AIDS, severe immune-compromised state, Faciomaxillary cancer, and other malignancies 2. Patients with uncontrolled diabetes mellitus, hypertension, hypothyroidism, and dyslipidemia 3. Patient self-reporting of taking chemotherapeutic agents, immunosuppressive medicines, teratogenic drugs, and anti-coagulant medications 3. Suffering from known severe psychiatric disorders like bipolar disorders, schizophrenia, and severe insanity. 4. Undergone surgery related to TMJ dysfunction 5. Pregnant and lactating mothers 6. Not willing to give voluntary informed consent

Design outcomes

Primary

MeasureTime frame
Graded Chronic Pain ScaleTimepoint: Baseline and every month for 3 months

Secondary

MeasureTime frame
Jaw Functional Limitation Scale (JFLS) – Long formTimepoint: Baseline and every month for 3 months;Patient Health Questionnaire – 4 (PHQ4)Timepoint: Baseline and at the end of 3rd month;Proportion of cases requiring conventional medicines/surgery and mean medicine dosageTimepoint: Every month follow-up for 3 months;Proportion of adverse events occurring during the study periodTimepoint: From recruitment till end of study

Countries

India

Contacts

Public ContactVaranasi Roja

Regional Research Institute for Homoeopathy, Siliguri

baibhms@gmail.com91-9239297736

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 17, 2026